Free 7 Day Trial
$39/Month
Learn More
$69/Month
Learn More
$79/Month
Learn More
$99/Month
Learn More
No headlines found.
Globe Newswire 16-Jan 8:28 AM
Globe Newswire 3-Jan 8:28 AM
Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
Globe Newswire 20-Dec 4:50 PM
Viveve Announces Closing of Public Offering of Shares of Common Stock
Globe Newswire 11-Dec 4:05 PM
Viveve Announces Pricing of Public Offering of Shares of Common Stock
Globe Newswire 6-Dec 9:49 PM
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study
Globe Newswire 6-Dec 4:03 PM
Viveve Announces Proposed Public Offering of Shares of Common Stock
Globe Newswire 6-Dec 4:01 PM
Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders
Globe Newswire 29-Nov 8:28 AM
Stock Price | Full Chart
Stock Volume
Correlated Symbol | Name | Sector | R-Squared | Beta | Current Price | % Chg |
---|
This correlation is calculated using one year's worth of weekly returns.
An R-Squared of 1.00 is the maximum value. Beta is only significant when the R-Squared is a high value.
Track Your Favorite Stocks |
|
Limited Time Offer:
Claim your free copy of income expert Bryan Perry's new report:
My Top Monthly Dividend Payer (8% Dividend Yield)
You'll also receive Bryan Perry's weekly e-letter, Dividend Investing Weekly, at no cost, along with other associated financial content and special offers.